Aurobindo Pharma clarifies on news of recalling products in US market; Stock dips 1.5%

The Company confirmed on the matter which involved recall of 2,820 bottles of Metoprolol tartrate tablets in the US market.

Oct 05, 2021 02:10 IST India Infoline News Service

Aurobindo Pharma
Aurobindo Pharma Ltd has clarified to the exchange regarding news item captioned "Drug makers Glenmark, Aurobindo Pharma recall products in US market" 

The Company confirmed on the matter which involved recall of 2,820 bottles of Metoprolol tartrate tablets in the US market, and the recall was done at the pharmacy level.

"As the matter was not material in nature, the same did not warrant disclosure to the Stock Exchanges under SEBI guidelines", said the company in a regulatory filing.

At around 2:30 PM, Aurobindo Pharma was trading at Rs721 apiece down by Rs11.1 or 1.52%. The stocks touched intraday high and intraday low at Rs734.95 and Rs718.40 respectively during early trading deals on Tuesday.

Related Story

Open Free Demat Account (Rs699)
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity